Taysha Gene Therapies
TSHA
#7343
Rank
โ‚น30.63 B
Marketcap
โ‚น149.46
Share price
-1.15%
Change (1 day)
-20.16%
Change (1 year)

Taysha Gene Therapies (TSHA) - Cash on Hand

Cash on Hand as of December 2024 : โ‚น12.08 Billion

According to Taysha Gene Therapies's latest financial reports the company has โ‚น12.08 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Taysha Gene Therapies - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น11.92 B-0.46%
2023-12-31โ‚น11.98 B64.78%
2022-12-31โ‚น7.27 B-34.47%
2021-12-31โ‚น11.09 B-39.6%
2020-12-31โ‚น18.37 B
2019-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น22.24 B 84.10%๐Ÿ‡บ๐Ÿ‡ธ USA